A Novel and Rapid Platform to Generate Gram-level Antibodies for Diagnostic and Therapeutic Use

Antibody drug discovery and development is a long and arduous journey. It starts with identifying new therapeutic antibodies to treat different diseases.

The CHO expression system is the most frequently used non-human mammalian cell line for developing and generating biological therapeutics. The CHO system is favored for its resilience to variations in growth conditions and resistance to infections.

The origin and biology of SARS-CoV-2, the virus responsible for the COVID-19 pandemic will be discussed. More specifically, we will detail how our immune system responds to infection, how variants such as Omicron emerge, and we will delineate the differen

Making Therapeutic Antibodies Simple, Fast and Safe

Protein interactions orchestrate cellular processes, but their analysis is challenging, especially in the native context. This webcast will explore the feasibility of deriving vital structural insights for protein communities in endogenous cellular extrac

Llama-derived nanobodies in the fight against Parkinson’s disease

Enhance your Western Blot Workflow with Advanced Technology

Emerging trends and technologies in gene and cell therapy

CRISPR-Cas is an adaptive immune system of prokaryotes (bacteria and archaea)